Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H, et al. Recommendation from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007;18:1927–34.

Article  CAS  PubMed  Google Scholar 

Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy: a review. JAMA Oncol. 2017;3:549–55.

Article  PubMed  PubMed Central  Google Scholar 

Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. Pathobiology of preoperative chemotherapy: findings from the national surgical adjuvant breast and bowel (NSABP) protocol B-18. Cancer. 2002;95:681–95.

Article  PubMed  Google Scholar 

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: The ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609–18.

Article  PubMed  Google Scholar 

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258–64.

Article  PubMed  Google Scholar 

Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0–T4, N1–N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263:802–7.

Article  PubMed  Google Scholar 

Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34:1072–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diego EJ, McAuliffe PF, Soran A, McGuire KP, Johnson RR, Bonaventura M, et al. Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes. Ann Surg Oncol. 2016;23:1549–53.

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network Clinical Practice Guidelines (NCCN Guidelines), breast cancer, Version 3.2022, NCCN.org.

Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261:378–82.

Article  PubMed  Google Scholar 

Simons JM, van Nijnatten TJA, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, et al. Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. JAMA Surg. 2022;157:991–9.

Article  PubMed  PubMed Central  Google Scholar 

Plecha D, Bai S, Patterson H, Thompson C, Shenk R. Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes. Ann Surg Oncol. 2015;22:4241–6.

Article  PubMed  Google Scholar 

Dashevsky BZ, Altman A, Abe H, Jaskowiak N, Bao J, Schacht DV, et al. Lymph node wire localization post-chemotherapy: towards improving the false negative sentinel lymph node biopsy rate in breast cancer patients. Clin Imaging. 2018;48:69–73.

Article  PubMed  Google Scholar 

Alarcón M, Buch E, Julve A, Hernandorena M, Tajahuerce M, Rodríguez H, et al. Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results? Surgeon. 2021;19:344–50.

Article  PubMed  Google Scholar 

Balasubramanian R, Morgan C, Shaari E, Kovacs T, Pinder SE, Hamed H, et al. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Eur J Surg Oncol. 2020;46:1028–33.

Article  PubMed  Google Scholar 

Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, et al. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: definitive results. Surg Oncol. 2021;38: 101636.

Article  PubMed  Google Scholar 

Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol. 2018;44:1307–11.

Article  PubMed  Google Scholar 

von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019;380:617–28.

Article  Google Scholar 

Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376:2147–59.

Article  CAS  PubMed  Google Scholar 

Nguyen TT, Hieken TJ, Glazebrook KN, Boughey JC. Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges. Ann Surg Oncol. 2017;24:3011–6.

Article  PubMed  Google Scholar 

Kuemmel S, Heil J, Rueland A, Seiberling C, Harrach H, Schindowski D, et al. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients. Ann Surg. 2022;276:e553–62.

Article  PubMed  Google Scholar 

Mariscal Martinez A, Vives Rosello I, Salazar Gomez A, Catanese A, Pérez Molina M, Solà Suarez M, et al. Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer. Surg Oncol. 2021;36:28–33.

Article  PubMed  Google Scholar 

Sun J, Henry DA, Carr MJ, Yazdankhahkenary A, Laronga C, Lee MC, et al. Feasibility of axillary lymph node localization and excision using radar refector localization. Clin Breast Cancer. 2021;21:e189–93.

Article  PubMed  Google Scholar 

Baker JL, Haji F, Kusske AM, Fischer CP, Hoyt AC, Thompson CK, et al. SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study. Breast Cancer Res Treat. 2022;191:107–14.

Article  CAS  PubMed  Google Scholar 

Siso C, Esgueva A, Rivero J, Morales C, Miranda I, Peg V, et al. Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment. Eur J Surg Oncol. 2023;49: 106938.

Article  PubMed  Google Scholar 

Brackstone M, Baldassarre FG, Perera FE, Cil T, Chavez Mac Gregor M, Dayes IS, et al. Management of the axilla in early-stage breast cancer ontario health (cancer care ontario) and asco guideline. J Clin Oncol. 2021;39:3056–82.

Article  PubMed  Google Scholar